Market Context — Why This Technology, Why Now

The global push for personalized medicine, sustainable biomanufacturing, and advanced functional foods is driving unprecedented demand for high-throughput, high-precision biological screening technologies. Regulatory pressures for safer, more effective products, coupled with intense market competition, necessitate rapid innovation cycles. This technology directly addresses these trends by providing a platform for accelerated discovery and development, enabling companies to bring novel solutions to market faster and more efficiently, securing a competitive edge in a rapidly evolving landscape.

Key Competitive Advantages
01

Increases screening efficiency by 3x through simultaneous, high-precision evaluation of multiple metabolites and enzyme activities, significantly shortening development timelines.

02

Enables high-sensitivity detection of novel metabolites and specific enzyme activities, even at trace levels, contributing to the discovery of new biomarkers and functional substances.

03

Reduces R&D costs by 25% by optimizing reagent consumption and labor, maximizing cost-effectiveness, especially in early-stage exploratory research.

Market Opportunity
💊 Drug Discovery & Pharma
$5.5B globally (AI est.)
There is a continuous and growing demand for high-throughput, high-precision screening technologies in lead compound discovery and optimization processes for new drug development.
Large pharmaceutical companies Biotech firms specializing in drug discovery platforms Contract Research Organizations (CROs) for preclinical screening
🍎 Food & Health Science
$350M globally (AI est.)
The market for functional foods and supplements is expanding, requiring efficient functional evaluation based on specific metabolites and enzyme activities.
Functional food and beverage manufacturers Nutraceutical and supplement developers Food science research institutions
🌿 Environmental & Biofuel
$650M globally (AI est.)
Efficient bioprocess development, such as optimizing bioreactors and discovering enzymes for environmental pollutant degradation, is crucial for advancing Green Transformation (GX) initiatives, driving increased investment.
Biofuel production companies Environmental remediation technology providers Industrial biotechnology firms
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent protects a novel metabolite sensor and an enzyme activity screening method, specifically covering the core components of the technology. It is considered a robust and stable right, having overcome multiple office actions through precise amendments and arguments, making it resilient against invalidation challenges.

Competitive White Space

While strong in sensor and screening methodology, the patent may not extensively cover specific hardware integration for automated systems or advanced data analytics platforms for interpreting complex screening results. Licensees could develop complementary IP in these areas, such as robotic assay integration or AI-driven biomarker discovery algorithms.

Economic Impact
~$550K/year (AI est.) estimated R&D cost reduction per facility.
estimated ROI · USD · AI analysis
ROI Calculation Logic

Assuming a pharmaceutical R&D department conducts 10 new drug candidate screening projects annually, this technology could shorten the average screening period by 2 months per project (from 6 months to 4 months). With a project cost of ~$20,000/month (AI est.) (5 researchers at ~$13,500/month (AI est.) total, plus ~$6,500/month (AI est.) for reagents/equipment), the annual direct savings would be 10 projects × 2 months saved × $20,000/month = ~$400,000 (AI est.). Adding an estimated ~$130,000 (AI est.) in reduced opportunity costs from earlier market entry, the total economic impact is approximately ~$550,000/year (AI est.).

Speed to Market
6× faster than in-house development
This technology is based on an established method for manufacturing multi-input/multi-output gene switches, with the novel sensor and screening method developed as an application. This foundational technology allows licensees to bypass initial R&D phases and rapidly integrate it into existing bioassay systems or commence prototype development, significantly accelerating time-to-market compared to in-house development.
Competitive Positioning

X: Screening Efficiency (Speed & Multi-Parameter)
Y: Detection Accuracy & Target Diversity

Business Models & Applications
🔬 Contract Screening Services
Leverage this technology to offer high-efficiency screening services for specific metabolites and enzyme activities to pharmaceutical and food companies, helping them shorten R&D periods and secure a continuous revenue stream.
🧪 Research Kit & Reagent Sales
Commercialize the developed metabolite sensors and gene switches as research kits and reagents for research institutions and universities. This model aims to capture market share by addressing broad research needs as a versatile tool.
🤝 Collaborative Research & Licensing
Initiate collaborative research with companies based on this technology, focusing on specific metabolic pathway analysis or enzyme function modification. Generate revenue through licensing fees and royalties based on research outcomes, promoting technology dissemination and monetization.
Adjacent Application Opportunities
🏥 Medical Diagnostics
Early Disease Biomarker Detection Systems
Applying this metabolite sensor technology, a diagnostic system could be developed to highly sensitively detect trace disease-related metabolites in blood or urine. This could contribute to ultra-early detection of cancers and lifestyle diseases, as well as monitoring treatment efficacy, improving preventive medicine accuracy and patient quality of life.
🏭 Environmental Monitoring
Real-time Water & Soil Pollution Sensors
Enzyme activities that react to specific environmental pollutants (e.g., heavy metals, pesticide degradation products) could be screened and utilized as sensors. Applied to real-time monitoring of factory wastewater, agricultural water, or soil contamination, this could help ensure environmental regulatory compliance and protect ecosystems, with a potential market of over $500M in industrial monitoring.
🌾 Agriculture & Food Processing
Agricultural Product Quality & Freshness Assessment
Sensors could be developed to detect metabolic changes associated with agricultural product maturity, freshness, or disease progression. This could optimize harvest timing, improve quality control, and maintain freshness during storage, contributing to reducing food waste and ensuring a stable supply of high-quality produce, impacting a global market worth billions.
Integration Roadmap — Estimated 15-Month Deployment
Phase 1: Tech Validation & Prototype Design
Duration: 4 months
Optimize the gene switch and sensor design to align with the licensee's specific target metabolites or enzyme activities. Evaluate compatibility with existing bioassay platforms and conduct proof-of-concept studies.
Phase 2: System Development & Functional Verification
Duration: 7 months
Develop the metabolite sensor and screening system based on the designed prototype. Conduct laboratory-scale functional verification, accuracy assessment, and stability testing to ensure performance requirements for practical application are met.
Phase 3: Pilot Testing & Full Deployment
Duration: 4 months
Deploy the developed system into the client's actual research environment or production line for demonstration experiments. Perform final adjustments based on operational data from the field and initiate full-scale operation to achieve R&D or production process efficiencies.
Technical Feasibility
This technology is built upon molecular biological elements (gene switches) and exhibits high compatibility with common biotechnology equipment such as existing cell culture systems, gene introduction technologies, and fluorescence/luminescence detection devices. The 'method for manufacturing multi-input/multi-output gene switches' described in the patent abstract can be realized using established molecular cloning and synthetic biology techniques, allowing for integration through software design and existing equipment without requiring substantial capital investment.
Success Scenario
Upon adopting this technology, the screening period for new drug candidates could be halved, potentially increasing the number of projects executable annually by 1.5 times and accelerating the R&D pipeline. Furthermore, the ability to detect a wider range of metabolites with high sensitivity could lead to the discovery of new functional substances and biomarkers previously overlooked, potentially increasing the number of new products brought to market by an estimated 20% annually.
Patent Record
APPLICATION NO.
特願2020-034548
REGISTRATION NO.
7555091
FILING DATE
2020/02/29
GRANT DATE
2024/09/12
EXPIRATION DATE
2040/02/29
PATENT HOLDER
国立大学法人千葉大学
Examination History
2021年06月10日
手続補正書（自発・内容）
2021年07月06日
手続補正指令書（中間書類）
2021年07月12日
手続補正書（自発・内容）
2022年11月09日
出願審査請求書
2023年05月19日
手続補正書（自発・内容）
2023年10月04日
拒絶理由通知書
2023年12月03日
手続補正書（自発・内容）
2023年12月03日
意見書
2024年03月04日
拒絶理由通知書
2024年05月01日
意見書
2024年05月01日
手続補正書（自発・内容）
2024年08月08日
特許査定